Immunotherapy shows promising results

A new study, among the first to evaluate sublingual immunotherapy (SLIT) as a peanut allergy treatment found the method can reduce the allergic response to peanut in adolescents and adults

Sublingual Immunotherapy, the practice of treating food allergies without injection by slowly building up a tolerance by placing tiny amounts of the allergen under a patient’s tongue to decrease their sensitivity to it.

The National Institutes of Health supported study of 40 participants aged 12 to 37 revealed 70 percent of candidates undergoing sublingual immunotherapy (SLIT) were able to consume at least ten times more peanut powder after 44 weeks of treatment.

Although the results are promising researchers say more work is needed.

Please be advised: SLIT should only ever be administered under medical guidance.

Speak Your Mind

*

INFORMATION on triggerallergy.com IS NOT MEDICAL ADVICE and any information or materials posted are intended for general informational purposes only. Any information posted on the web site is NOT a substitute for medical attention. Please see your health-care professional for medical advice and treatment.